Author:
Link-Gelles Ruth,Levy Matthew E.,Gaglani Manjusha,Irving Stephanie A.,Stockwell Melissa,Dascomb Kristin,DeSilva Malini B.,Reese Sarah E.,Liao I-Chia,Ong Toan C.,Grannis Shaun J.,McEvoy Charlene,Patel Palak,Klein Nicola P.,Hartmann Emily,Stenehjem Edward,Natarajan Karthik,Naleway Allison L.,Murthy Kempapura,Rao Suchitra,Dixon Brian E.,Kharbanda Anupam B.,Akinseye Akintunde,Dickerson Monica,Lewis Ned,Grisel Nancy,Han Jungmi,Barron Michelle A.,Fadel William F.,Dunne Margaret M.,Goddard Kristin,Arndorfer Julie,Konatham Deepika,Valvi Nimish R.,Currey J. C.,Fireman Bruce,Raiyani Chandni,Zerbo Ousseny,Sloan-Aagard Chantel,Ball Sarah W.,Thompson Mark G.,Tenforde Mark W.
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference10 articles.
1. Neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5.;Hachmann;N Engl J Med,2022
2. Protection against the Omicron variant from previous SARS-CoV-2 infection.;Altarawneh;N Engl J Med,2022
3. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.;Feikin;Lancet,2022
4. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2022. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and
5. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings.;Thompson;N Engl J Med,2021